Evidera to Join PPD

Article

PPD announces the acquisition of Evidera, an evidence-based solutions provider.

PPD announces the acquisition of Evidera, an evidence-based solutions provider. As a subsidiary of PPD, Evidera will be deliver peri- and post-approval studies, health economics, outcomes research, epidemiology and market access consulting.

Read the full release here

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Recent Videos
Related Content
© 2025 MJH Life Sciences

All rights reserved.